Special Opinion of the Board of Directors on the Independence Assessment of Independent Directors

✨ AI Summary

The board of Kunming Longjin Pharmaceutical Co., Ltd. assessed the independence of independent directors Zhang Shuang, Xu Hui, and Wei Lijun for the year 2024. The evaluation confirmed that these individuals hold no positions other than independent directors and have no conflicts of interest with the company or its major shareholders. They meet the relevant independence requirements set forth by applicable laws and regulations.

Summary generated by AI · Always verify with source document